закрити [x]
приховати бюлетень | кошик

CoronaVac COVID-19 vaccine (60)

190x60
New Rada

кошики

Ви повинні увійти в систему, щоб мати доступ до кошика

 

EN_01471659_0003
EN_01471659_0003

210404 -- MANILA, April 4, 2021 -- A resident is inoculated with a dose of CoronaVac COVID-19 vaccine, made by Sinovac Biotech, at a vaccination site in Manila, the Philippines on April 4, 2021. The Philippines Department of Health DOH reported 11,028 new COVID-19 infections on Sunday, bringing the total number of confirmed cases in the Southeast Asian country to 795,051. The death toll climbed to 13,425 after two more patients died from the viral disease, the DOH said. PHILIPPINES-MANILA-COVID-19-VACCINATION RouellexUmali PUBLICATIONxNOTxINxCHN

EN_01471659_0004
EN_01471659_0004

210404 -- MANILA, April 4, 2021 -- A resident is inoculated with a dose of CoronaVac COVID-19 vaccine, made by Sinovac Biotech, at a vaccination site in Manila, the Philippines on April 4, 2021. The Philippines Department of Health DOH reported 11,028 new COVID-19 infections on Sunday, bringing the total number of confirmed cases in the Southeast Asian country to 795,051. The death toll climbed to 13,425 after two more patients died from the viral disease, the DOH said. PHILIPPINES-MANILA-COVID-19-VACCINATION RouellexUmali PUBLICATIONxNOTxINxCHN

EN_01471659_0005
EN_01471659_0005

210404 -- MANILA, April 4, 2021 -- A resident is inoculated with a dose of CoronaVac COVID-19 vaccine, made by Sinovac Biotech, at a vaccination site in Manila, the Philippines on April 4, 2021. The Philippines Department of Health DOH reported 11,028 new COVID-19 infections on Sunday, bringing the total number of confirmed cases in the Southeast Asian country to 795,051. The death toll climbed to 13,425 after two more patients died from the viral disease, the DOH said. PHILIPPINES-MANILA-COVID-19-VACCINATION RouellexUmali PUBLICATIONxNOTxINxCHN

EN_01471659_0006
EN_01471659_0006

210404 -- MANILA, April 4, 2021 -- A resident shows a box of CoronaVac COVID-19 vaccine, made by Sinovac Biotech, after being inoculated at a vaccination site in Manila, the Philippines on April 4, 2021. The Philippines Department of Health DOH reported 11,028 new COVID-19 infections on Sunday, bringing the total number of confirmed cases in the Southeast Asian country to 795,051. The death toll climbed to 13,425 after two more patients died from the viral disease, the DOH said. PHILIPPINES-MANILA-COVID-19-VACCINATION RouellexUmali PUBLICATIONxNOTxINxCHN

EN_01471569_0667
EN_01471569_0667

Brazilian former president (2003-2011) Luiz Inacio Lula da Silva receives the second dose of Sinovac's CoronaVac vaccine against the coronavirus disease (COVID-19) in Sao Bernardo do Campo, near Sao Paulo, Brazil, on April 3, 2021. (Photo by Miguel SCHINCARIOL / AFP)

EN_01471569_0668
EN_01471569_0668

Brazilian former president (2003-2011) Luiz Inacio Lula da Silva receives the second dose of Sinovac's CoronaVac vaccine against the coronavirus disease (COVID-19) in Sao Bernardo do Campo, near Sao Paulo, Brazil, on April 3, 2021. (Photo by Miguel SCHINCARIOL / AFP)

EN_01471569_0669
EN_01471569_0669

Brazilian former president (2003-2011) Luiz Inacio Lula da Silva receives the second dose of Sinovac's CoronaVac vaccine against the coronavirus disease (COVID-19) in Sao Bernardo do Campo, near Sao Paulo, Brazil, on April 3, 2021. (Photo by Miguel SCHINCARIOL / AFP)

EN_01471569_0670
EN_01471569_0670

Brazilian former president (2003-2011) Luiz Inacio Lula da Silva receives the second dose of Sinovac's CoronaVac vaccine against the coronavirus disease (COVID-19) in Sao Bernardo do Campo, near Sao Paulo, Brazil, on April 3, 2021. (Photo by Miguel SCHINCARIOL / AFP)

EN_01471409_0735
EN_01471409_0735

Thailand's Deputy Prime Minister and Health Minister Anutin Charnvirakul is gifted with a traditional Karen shirt as he arrives to hand over 2,000 vials of the CoronaVac vaccine and other medical supplies to frontline workers to combat the spread of the Covid-19 coronavirus, as authorities fear a further influx of Myanmar refugees over the border, at Mae Sariang Hospital in Mae Hong Son province on April 2, 2021. (Photo by Lillian SUWANRUMPHA / AFP)

EN_01471409_0736
EN_01471409_0736

Thailand's Deputy Prime Minister and Health Minister Anutin Charnvirakul (top R), wearing a traditional Karen shirt, watches as nurses administer the Coronavac vaccine to frontline health workers after he arrived to hand over 2,000 vials of the vaccine and other medical supplies to frontline workers to combat the spread of the Covid-19 coronavirus, as authorities fear a further influx of Myanmar refugees over the border, at Mae Sariang Hospital in Mae Hong Son province on April 2, 2021. (Photo by Lillian SUWANRUMPHA / AFP)

EN_01471409_0737
EN_01471409_0737

Thailand's Deputy Prime Minister and Health Minister Anutin Charnvirakul, wearing a traditional Karen shirt, greets local volunteer guards as he hands over 2,000 vials of the Coronavac vaccine and other medical supplies to frontline workers to combat the spread of the Covid-19 coronavirus, as authorities fear a further influx of Myanmar refugees over the border, at Mae Sariang Hospital in Mae Hong Son province on April 2, 2021. (Photo by Lillian SUWANRUMPHA / AFP)

EN_01471409_0740
EN_01471409_0740

Thailand's Deputy Prime Minister and Health Minister Anutin Charnvirakul (R), wearing a traditional Karen shirt, handles a box of the Coronavac vaccine, as he hands over 2,000 vials of the vaccine and other medical supplies to frontline workers to combat the spread of the Covid-19 coronavirus, as authorities fear a further influx of Myanmar refugees over the border, at Mae Sariang Hospital in Mae Hong Son province on April 2, 2021. (Photo by Lillian SUWANRUMPHA / AFP)

EN_01471409_0741
EN_01471409_0741

Thailand's Deputy Prime Minister and Health Minister Anutin Charnvirakul, wearing a traditional Karen shirt, handles a vial of the Coronavac vaccine, as he hands over 2,000 vials of the vaccine and other medical supplies to frontline workers to combat the spread of the Covid-19 coronavirus, as authorities fear a further influx of Myanmar refugees over the border, at Mae Sariang Hospital in Mae Hong Son province on April 2, 2021. (Photo by Lillian SUWANRUMPHA / AFP)

EN_01471409_0742
EN_01471409_0742

Thailand's Deputy Prime Minister and Health Minister Anutin Charnvirakul arrives to hand over 2,000 vials of the Coronavac vaccine and other medical supplies to frontline workers to combat the spread of the Covid-19 coronavirus, as authorities fear a further influx of Myanmar refugees over the border, at Mae Sariang Hospital in Mae Hong Son province on April 2, 2021. (Photo by Lillian SUWANRUMPHA / AFP)

EN_01471409_0743
EN_01471409_0743

Thailand's Deputy Prime Minister and Health Minister Anutin Charnvirakul (R), wearing a traditional Karen shirt, greets a health worker receiving the Coronavac vaccine, after he arrived to hand over 2,000 vials of the vaccine and other medical supplies to frontline workers to combat the spread of the Covid-19 coronavirus, as authorities fear a further influx of Myanmar refugees over the border, at Mae Sariang Hospital in Mae Hong Son province on April 2, 2021. (Photo by Lillian SUWANRUMPHA / AFP)

EN_01471409_0744
EN_01471409_0744

A nurse administers the Coronavac vaccine to a frontline health worker after Thailand's Deputy Prime Minister and Health Minister Anutin Charnvirakul arrived to hand over 2,000 vials of the Coronavac vaccine and other medical supplies to frontline workers to combat the spread of the Covid-19 coronavirus, as authorities fear a further influx of Myanmar refugees over the border, at Mae Sariang Hospital in Mae Hong Son province on April 2, 2021. (Photo by Lillian SUWANRUMPHA / AFP)

EN_01471409_0745
EN_01471409_0745

A nurse administers the Coronavac vaccine to a local volunteer guard after Thailand's Deputy Prime Minister and Health Minister Anutin Charnvirakul arrived to hand over 2,000 vials of the Coronavac vaccine and other medical supplies to frontline workers to combat the spread of the Covid-19 coronavirus, as authorities fear a further influx of Myanmar refugees over the border, at Mae Sariang Hospital in Mae Hong Son province on April 2, 2021. (Photo by Lillian SUWANRUMPHA / AFP)

EN_01471409_0746
EN_01471409_0746

Thailand's Deputy Prime Minister and Health Minister Anutin Charnvirakul, wearing a traditional Karen shirt, watches nurses administer the Coronavac vaccine to frontline health workers after he arrived to hand over 2,000 vials of the vaccine and other medical supplies to frontline workers to combat the spread of the Covid-19 coronavirus, as authorities fear a further influx of Myanmar refugees over the border, at Mae Sariang Hospital in Mae Hong Son province on April 2, 2021. (Photo by Lillian SUWANRUMPHA / AFP)

EN_01471409_0747
EN_01471409_0747

Thailand's Deputy Prime Minister and Health Minister Anutin Charnvirakul (C), wearing a traditional Karen shirt, greets local volunteer guards as he hands over 2,000 vials of the Coronavac vaccine and other medical supplies to frontline workers to combat the spread of the Covid-19 coronavirus, as authorities fear a further influx of Myanmar refugees over the border, at Mae Sariang Hospital in Mae Hong Son province on April 2, 2021. (Photo by Lillian SUWANRUMPHA / AFP)

EN_01471274_0899
EN_01471274_0899

A patient is vaccinated against the Covid-19 virus in Ankara on April 1, 2021. Ankara. - Turkey is relying on the Chinese firm Sinovac's CoronaVac for the bulk of its inoculation effort and only received the first 1.4 million doses of the Pfizer-BioNTech vaccine this week. (Photo by Adem ALTAN / AFP)

EN_01471274_0900
EN_01471274_0900

A patient is vaccinated against the Covid-19 virus in Ankara on April 1, 2021. Ankara. - Turkey is relying on the Chinese firm Sinovac's CoronaVac for the bulk of its inoculation effort and only received the first 1.4 million doses of the Pfizer-BioNTech vaccine this week. (Photo by Adem ALTAN / AFP)

EN_01471274_0901
EN_01471274_0901

A patient is vaccinated against the Covid-19 virus in Ankara on April 1, 2021. Ankara. - Turkey is relying on the Chinese firm Sinovac's CoronaVac for the bulk of its inoculation effort and only received the first 1.4 million doses of the Pfizer-BioNTech vaccine this week. (Photo by Adem ALTAN / AFP)

EN_01471274_0905
EN_01471274_0905

A women waits to receive the COVID-19 vaccine in Ankara in Ankara on April 1, 2021. Ankara. - Turkey is relying on the Chinese firm Sinovac's CoronaVac for the bulk of its inoculation effort and only received the first 1.4 million doses of the Pfizer-BioNTech vaccine this week. (Photo by Adem ALTAN / AFP)

EN_01471131_1728
EN_01471131_1728

A woman is inoculated against the novel coronavirus, COVID-19, with a jab of China's Sinovac CoronaVac vaccine produced by Butantan, the largest vaccine producer in Brazil, at a vaccination centre mounted at the Cidade das Artes cultural complex in Rio de Janeiro, on March 31, 2021. (Photo by Mauro PIMENTEL / AFP)

EN_01471131_1729
EN_01471131_1729

A woman (R) is inoculated against the novel coronavirus, COVID-19, with a jab of China's Sinovac CoronaVac vaccine produced by Butantan, the largest vaccine producer in Brazil, at a vaccination centre mounted at the Cidade das Artes cultural complex in Rio de Janeiro, on March 31, 2021. (Photo by Mauro PIMENTEL / AFP)

EN_01471131_1730
EN_01471131_1730

A woman (bottom) is inoculated against the novel coronavirus, COVID-19, with a jab of China's Sinovac CoronaVac vaccine produced by Butantan, the largest vaccine producer in Brazil, at a vaccination centre mounted at the Cidade das Artes cultural complex in Rio de Janeiro, on March 31, 2021. (Photo by Mauro PIMENTEL / AFP)

EN_01471131_1731
EN_01471131_1731

People are inoculated against the novel coronavirus, COVID-19, with a jab of China's Sinovac CoronaVac vaccine produced by Butantan, the largest vaccine producer in Brazil, at a vaccination centre mounted at the Cidade das Artes cultural complex in Rio de Janeiro, on March 31, 2021. (Photo by Mauro PIMENTEL / AFP)

EN_01471131_1732
EN_01471131_1732

A woman is inoculated against the novel coronavirus, COVID-19, with a jab of China's Sinovac CoronaVac vaccine produced by Butantan, the largest vaccine producer in Brazil, at a vaccination centre mounted at the Cidade das Artes cultural complex in Rio de Janeiro, on March 31, 2021. (Photo by Mauro PIMENTEL / AFP)

EN_01471131_1736
EN_01471131_1736

A man is inoculated against the novel coronavirus, COVID-19, with a jab of China's Sinovac CoronaVac vaccine produced by Butantan, the largest vaccine producer in Brazil, at a vaccination centre mounted at the Cidade das Artes cultural complex in Rio de Janeiro, on March 31, 2021. (Photo by Mauro PIMENTEL / AFP)

EN_01471131_1737
EN_01471131_1737

A man is inoculated against the novel coronavirus, COVID-19, with a jab of China's Sinovac CoronaVac vaccine produced by Butantan, the largest vaccine producer in Brazil, at a vaccination centre mounted at the Cidade das Artes cultural complex in Rio de Janeiro, on March 31, 2021. (Photo by Mauro PIMENTEL / AFP)

EN_01471131_1738
EN_01471131_1738

A man is inoculated against the novel coronavirus, COVID-19, with a jab of China's Sinovac CoronaVac vaccine produced by Butantan, the largest vaccine producer in Brazil, at a vaccination centre mounted at the Cidade das Artes cultural complex in Rio de Janeiro, on March 31, 2021. (Photo by Mauro PIMENTEL / AFP)

EN_01471131_1739
EN_01471131_1739

A man is inoculated against the novel coronavirus, COVID-19, with a jab of China's Sinovac CoronaVac vaccine produced by Butantan, the largest vaccine producer in Brazil, at a vaccination centre mounted at the Cidade das Artes cultural complex in Rio de Janeiro, on March 31, 2021. (Photo by Mauro PIMENTEL / AFP)

EN_01471131_1744
EN_01471131_1744

A man presses his arm after being inoculated against the novel coronavirus, COVID-19, with a jab of China's Sinovac CoronaVac vaccine produced by Butantan, the largest vaccine producer in Brazil, at a vaccination centre mounted at the Cidade das Artes cultural complex in Rio de Janeiro, on March 31, 2021. (Photo by Mauro PIMENTEL / AFP)

EN_01471131_1752
EN_01471131_1752

A man gets ready to be inoculated against the novel coronavirus, COVID-19, with a jab of China's Sinovac CoronaVac vaccine produced by Butantan, the largest vaccine producer in Brazil, at a vaccination centre mounted at the Cidade das Artes cultural complex in Rio de Janeiro, on March 31, 2021. (Photo by Mauro PIMENTEL / AFP)

EN_01471131_1753
EN_01471131_1753

A man waits for his turn to be inoculated against the novel coronavirus, COVID-19, with a jab of China's Sinovac CoronaVac vaccine produced by Butantan, the largest vaccine producer in Brazil, at a vaccination centre mounted at the Cidade das Artes cultural complex in Rio de Janeiro, on March 31, 2021. (Photo by Mauro PIMENTEL / AFP)

EN_01471131_1774
EN_01471131_1774

A woman holds a banner celebrating the SUS (Brazil's Public Health System) and calling Brazil's President Jair Bolsonaro a genocidal as she is inoculated against the novel coronavirus, COVID-19, with a jab of China's Sinovac CoronaVac vaccine produced by Butantan, the largest vaccine producer in Brazil, at a vaccination centre mounted at the Public Planetarium in Rio de Janeiro, on March 31, 2021. (Photo by Mauro PIMENTEL / AFP)

EN_01471131_1775
EN_01471131_1775

A nurse prepares a dose of China's Sinovac CoronaVac vaccine produced by Butantan, the largest vaccine producer in Brazil, at a vaccination centre against the novel coronavirus, COVID-19, mounted at the Public Planetarium in Rio de Janeiro, on March 31, 2021. (Photo by Mauro PIMENTEL / AFP)

EN_01471131_1776
EN_01471131_1776

A woman is inoculated against the novel coronavirus, COVID-19, with a jab of China's Sinovac CoronaVac vaccine produced by Butantan, the largest vaccine producer in Brazil, at a vaccination centre mounted at the Public Planetarium in Rio de Janeiro, on March 31, 2021. (Photo by Mauro PIMENTEL / AFP)

EN_01471131_1777
EN_01471131_1777

A nurse prepares a dose of China's Sinovac CoronaVac vaccine produced by Butantan, the largest vaccine producer in Brazil, at a vaccination centre against the novel coronavirus, COVID-19, mounted at the Public Planetarium in Rio de Janeiro, on March 31, 2021. (Photo by Mauro PIMENTEL / AFP)

EN_01471131_1778
EN_01471131_1778

A woman is inoculated against the novel coronavirus, COVID-19, with a jab of China's Sinovac CoronaVac vaccine produced by Butantan, the largest vaccine producer in Brazil, at a vaccination centre mounted at the Public Planetarium in Rio de Janeiro, on March 31, 2021. (Photo by Mauro PIMENTEL / AFP)

EN_01471131_1779
EN_01471131_1779

A nurse prepares a dose of China's Sinovac CoronaVac vaccine produced by Butantan, the largest vaccine producer in Brazil, at a vaccination centre against the novel coronavirus, COVID-19, mounted at the Public Planetarium in Rio de Janeiro, on March 31, 2021. (Photo by Mauro PIMENTEL / AFP)

EN_01471131_1780
EN_01471131_1780

A nurse prepares a dose of China's Sinovac CoronaVac vaccine produced by Butantan, the largest vaccine producer in Brazil, at a vaccination centre against the novel coronavirus, COVID-19, mounted at the Public Planetarium in Rio de Janeiro, on March 31, 2021. (Photo by Mauro PIMENTEL / AFP)

EN_01471131_1781
EN_01471131_1781

Brazilian actor Jonathan Azevedo takes a picture of her mother being inoculated against the novel coronavirus, COVID-19, with China's Sinovac CoronaVac vaccine produced by Butantan, the largest vaccine producer in Brazil, at a vaccination centre mounted at the Public Planetarium in Rio de Janeiro, on March 31, 2021. (Photo by Mauro PIMENTEL / AFP)

EN_01471131_1782
EN_01471131_1782

People queue to be inoculated against the novel coronavirus, COVID-19, with China's Sinovac CoronaVac vaccine produced by Butantan, the largest vaccine producer in Brazil, at a vaccination centre mounted at the Public Planetarium in Rio de Janeiro, on March 31, 2021. (Photo by Mauro PIMENTEL / AFP)

EN_01471131_1783
EN_01471131_1783

People wait for their tun to be inoculated against the novel coronavirus, COVID-19, with China's Sinovac CoronaVac vaccine produced by Butantan, the largest vaccine producer in Brazil, at a vaccination centre mounted at Catete Palace in Rio de Janeiro, on March 31, 2021. (Photo by Mauro PIMENTEL / AFP)

EN_01471131_1784
EN_01471131_1784

People queue to be inoculated against the novel coronavirus, COVID-19, with China's Sinovac CoronaVac vaccine produced by Butantan, the largest vaccine producer in Brazil, at a vaccination centre mounted at Catete Palace in Rio de Janeiro, on March 31, 2021. (Photo by Mauro PIMENTEL / AFP)

EN_01471131_1785
EN_01471131_1785

Men are inoculated against the novel coronavirus, COVID-19, with China's Sinovac CoronaVac vaccine produced by Butantan, the largest vaccine producer in Brazil, at a vaccination centre mounted at Catete Palace in Rio de Janeiro, on March 31, 2021. (Photo by Mauro PIMENTEL / AFP)

EN_01471131_1786
EN_01471131_1786

People wait for their tun to be inoculated against the novel coronavirus, COVID-19, with China's Sinovac CoronaVac vaccine produced by Butantan, the largest vaccine producer in Brazil, at a vaccination centre mounted at Catete Palace in Rio de Janeiro, on March 31, 2021. (Photo by Mauro PIMENTEL / AFP)

EN_01471131_1787
EN_01471131_1787

People queue to be inoculated against the novel coronavirus, COVID-19, with China's Sinovac CoronaVac vaccine produced by Butantan, the largest vaccine producer in Brazil, at a vaccination centre mounted at Catete Palace in Rio de Janeiro, on March 31, 2021. (Photo by Mauro PIMENTEL / AFP)

EN_01471131_1788
EN_01471131_1788

A man is being inoculated against the novel coronavirus, COVID-19, with China's Sinovac CoronaVac vaccine produced by Butantan, the largest vaccine producer in Brazil, at a vaccination centre mounted at Catete Palace in Rio de Janeiro, on March 31, 2021. (Photo by Mauro PIMENTEL / AFP)

EN_01471131_1789
EN_01471131_1789

A man holds a placard celebrating the SUS (Brazil's Health Public System) and calling the Brazil's president Jair Bolsonaro a genocidal as he waits to be inoculated against the novel coronavirus, COVID-19, with China's Sinovac CoronaVac vaccine produced by Butantan, the largest vaccine producer in Brazil, at a vaccination centre mounted at Catete Palace in Rio de Janeiro, on March 31, 2021. (Photo by Mauro PIMENTEL / AFP)

EN_01471131_0226
EN_01471131_0226

A member of the Santa Sofia indigenous community is inoculated with the CoronaVac vaccine -developed by China's Sinovac laboratory- against the novel coronavirus disease COVID-19, in Leticia, Amazonas Department, Colombia, on March 30, 2021. (Photo by Daniel PADILLA / AFP)

EN_01471131_0227
EN_01471131_0227

A member of the Santa Sofia indigenous community is inoculated with the CoronaVac vaccine -developed by China's Sinovac laboratory- against the novel coronavirus disease COVID-19, in Leticia, Amazonas Department, Colombia, on March 30, 2021. (Photo by Daniel PADILLA / AFP)

EN_01471131_0228
EN_01471131_0228

Members of the Santa Sofia indigenous community queue to be inoculated with the CoronaVac vaccine -developed by China's Sinovac laboratory- against the novel coronavirus disease COVID-19, in Leticia, Amazonas Department, Colombia, on March 30, 2021. (Photo by Daniel PADILLA / AFP)

EN_01471131_0229
EN_01471131_0229

Members of the Santa Sofia indigenous community queue to be inoculated with the CoronaVac vaccine -developed by China's Sinovac laboratory- against the novel coronavirus disease COVID-19, in Leticia, Amazonas Department, Colombia, on March 30, 2021. (Photo by Daniel PADILLA / AFP)

EN_01471131_0230
EN_01471131_0230

Members of the Santa Sofia indigenous community wait to be inoculated with the CoronaVac vaccine -developed by China's Sinovac laboratory- against the novel coronavirus disease COVID-19, in Leticia, Amazonas Department, Colombia, on March 30, 2021. (Photo by Daniel PADILLA / AFP)

EN_01471131_0231
EN_01471131_0231

Members of the Santa Sofia indigenous community wait to be inoculated with the CoronaVac vaccine -developed by China's Sinovac laboratory- against the novel coronavirus disease COVID-19, in Leticia, Amazonas Department, Colombia, on March 30, 2021. (Photo by Daniel PADILLA / AFP)

EN_01471131_0232
EN_01471131_0232

Members of the Santa Sofia indigenous community wait to be inoculated with the CoronaVac vaccine -developed by China's Sinovac laboratory- against the novel coronavirus disease COVID-19, in Leticia, Amazonas Department, Colombia, on March 30, 2021. (Photo by Daniel PADILLA / AFP)

EN_01471659_0001
EN_01471659_0001

210330 -- MONTEVIDEO, March 30, 2021 -- Uruguayan President Luis Lacalle Pou walks into a vaccination center in Montevideo, Uruguay, March 29, 2021. Luis Lacalle Pou on Monday got his first dose of the CoronaVac vaccine developed by Chinese pharmaceutical firm Sinovac against COVID-19. Photo by /Xinhua URUGUAY-MONTEVIDEO-PRESIDENT-CHINESE VACCINE NicolasxCelaya PUBLICATIONxNOTxINxCHN

EN_01471659_0002
EN_01471659_0002

210330 -- MONTEVIDEO, March 30, 2021 -- Uruguayan President Luis Lacalle Pou is surrounded by journalists after he receives a shot of Chinese COVID-19 vaccine in Montevideo, Uruguay, March 29, 2021. Luis Lacalle Pou on Monday got his first dose of the CoronaVac vaccine developed by Chinese pharmaceutical firm Sinovac against COVID-19. Photo by /Xinhua URUGUAY-MONTEVIDEO-PRESIDENT-CHINESE VACCINE NicolasxCelaya PUBLICATIONxNOTxINxCHN